1. Home
  2. ETON

ETON

Eton Pharmaceuticals Inc.

Logo Eton Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Founded: 2017 Country:
United States
United States
Employees: N/A City: DEER PARK
Market Cap: 88.4M IPO Year: 2018
Target Price: $10.00 AVG Volume (30 days): 63.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.04 EPS Growth: N/A
52 Week Low/High: $2.42 - $5.81 Next Earning Date: 05-09-2024
Revenue: $32,642,000 Revenue Growth: 42.60%
Revenue Growth (this year): 29.37% Revenue Growth (next year): N/A

Share on Social Networks: